Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy.
about
Decision aids for people considering taking part in clinical trialsDecision support interventions for people making decisions about participation in clinical trialsA systematic review of training programmes for recruiters to randomised controlled trialsDoes random treatment assignment cause harm to research participants?Participating in a trial in a critical situation: a qualitative study in pregnancyThe relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial.Open-access clinical trial registries: the Italian scenario.Improving swallowing outcomes in patients with head and neck cancer using a theory-based pretreatment swallowing intervention package: protocol for a randomised feasibility studyThe National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendationsA New Measure of Research Participant Burden: Brief ReportLinguistic Strategies for Improving Informed Consent in Clinical Trials Among Low Health Literacy Patients.Using marketing theory to inform strategies for recruitment: a recruitment optimisation model and the txt2stop experience.Reasons for participating in randomised controlled trials: conditional altruism and considerations for self.Research into complementary and alternative medicine: problems and potential.Monitoring clinical trials. Dissemination of decisions on interim analyses needs wider debateThe Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.Application of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) study.Assessing the impact of user-centered research on a clinical trial eHealth tool via counterbalanced research design.Development of a measure to assess patient trust in medical researchers.Using a business model approach and marketing techniques for recruitment to clinical trialsFeasibility, acceptability and findings from a pilot randomized controlled intervention study on the impact of a book designed to inform patients about cancer clinical trials.Satisfaction of the uncertainty principle in cancer clinical trials: retrospective cohort analysis.Characteristics and outcomes of patients with advanced gastric cancer who declined to participate in a randomized clinical chemotherapy trialParticipant experiences of an internet-based intervention and randomised control trial: interview studyUndergraduate research involving human subjects should not be granted ethical approval unless it is likely to be of publishable quality.Why patients don't take part in cancer clinical trials: an overview of the literature.Participants' understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis.A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy.Duty, desire or indifference? A qualitative study of patient decisions about recruitment to an epilepsy treatment trial.Factors influencing participation in a randomized controlled resistance exercise intervention study in breast cancer patients during radiotherapy.Improving recruitment in clinical trials: why eligible participants declineFor the Benefit of Others: Reasons Why Women with Breast Cancer Participate in RCTsAligning the goals of community-engaged research: why and how academic health centers can successfully engage with communities to improve healthMotivational assessment of non-treatment buprenorphine research participation in heroin dependent individuals.Why do - or don't - patients with urinary tract infection participate in a clinical trial? A qualitative study in German family medicine.Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey.Does cancer research focus on areas of importance to patients?Patient-doctor agreement on recall of clinical trial discussion across culturesChallenges and successes of recruitment in the "angiotensin-converting enzyme inhibition in infants with single ventricle trial" of the Pediatric Heart Network.A randomised controlled study of an audiovisual patient information intervention on informed consent and recruitment to cancer clinical trials
P2860
Q24187609-E105EE46-3692-43A5-82F9-C3E34675E924Q24201579-2CC6FD50-E1CA-4819-AC86-EF09C3B92904Q26785411-A1C9A859-D7DA-4E37-93E0-DD0A4265FF38Q28768704-76E9F57E-DD74-476D-98F4-8BDC893E6176Q28816154-56901C7F-C1AE-439A-8FD7-2F8C5976A5A0Q30224746-6C77DFD2-ACD6-4DFE-8A82-D75D721060F8Q30485749-14138592-FB68-47F1-967D-58C7196858C3Q30491240-D09A70AF-7349-4E50-A4BF-AA7D4444F69FQ30557206-02469792-BC55-45A9-88D1-7E6C58BBB517Q30656231-F8AAFE76-4BA5-4A47-B8CB-A61864594FA2Q30852729-4FD18CBC-5B17-4BAA-9D2B-E63E1E239860Q33755052-D3DBF583-3F4B-41AF-A949-FE82DB41DD1DQ33764230-174EBB82-CD82-4419-B386-CC2745A46304Q33803779-C51AE32B-AEBC-47FB-B189-0CFD6B75FAA4Q33808390-70C6DA98-252A-443F-9BC5-2044AB587768Q33865329-F6C3135E-D00D-46E3-A10A-0CCC97C9D694Q34224032-DD81C69E-367C-4F21-A3BC-D79A0C0EC817Q34424083-4964ECAA-3E8E-48F7-961C-FA0AF63ED81AQ34682222-316D0F94-27FE-4597-9EC7-867FD3BCC0DEQ34712827-D86AC36C-BA82-42C3-A86C-45AFC3504C2AQ34789236-3F3330C8-EA2B-4B58-A59E-84CF44C66511Q34841125-651EA0C0-3AD2-42E2-9A72-794AB53A3CBBQ34974888-E26B41AE-CB14-4A26-9B3B-DFA4056FA065Q35027336-03F72D28-B4E5-42EA-97AB-D5233BF76946Q35077277-B875BE81-5C7A-4C7B-8376-1D359554EF90Q35145266-817C1424-5A81-4CB4-B50F-C6C43D8F568FQ35211304-F4D042C8-1E4D-48B1-B076-9B29BF2F35F4Q35443771-C1130F2C-29EC-4780-A35D-5301998954D3Q35589235-A0D292BC-8F8C-4983-B5B4-6B8EBBA4F794Q35606109-874B7407-5CAA-481C-8921-B82D489BBAC9Q35654144-ED3A9881-8304-4A05-8D80-1F5644F1A3AFQ35726028-584299F2-70B2-48F5-B175-4005080AE703Q35799237-CA99E311-553E-412F-8207-238D04D277DEQ35836541-521F7C6E-BE7A-4C9B-AD51-F8AA6C750D42Q36162570-152D5CDF-D5BF-44FD-888B-4DE6925EEBCBQ36446227-887B13E6-C8C8-4DF0-8378-0C9C18DF333DQ36483689-6031ABE5-6F9F-4ED9-B530-DD7C4708C3A6Q36551625-0B9119FE-1EF6-415B-80EA-7A9C9142B065Q36585822-8424F9EF-ED35-47A1-AE64-E3F16D3ACE5AQ36611162-5701DC5C-D2B8-4015-8F57-EDA979C0B749
P2860
Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Reasons for accepting or decli ...... cal trials for cancer therapy.
@ast
Reasons for accepting or decli ...... cal trials for cancer therapy.
@en
type
label
Reasons for accepting or decli ...... cal trials for cancer therapy.
@ast
Reasons for accepting or decli ...... cal trials for cancer therapy.
@en
prefLabel
Reasons for accepting or decli ...... cal trials for cancer therapy.
@ast
Reasons for accepting or decli ...... cal trials for cancer therapy.
@en
P2860
P356
P1476
Reasons for accepting or decli ...... cal trials for cancer therapy.
@en
P2093
Fallowfield L
P2860
P2888
P304
P356
10.1054/BJOC.2000.1142
P407
P577
2000-06-01T00:00:00Z
P5875
P6179
1052170560